ArthroCare Focuses on Diabetic Foot Ulcers Treatment
Posted on: Thursday, 27 March 2008, 12:00 CDT
ArthroCare Sports Medicine has launched early stage clinical and pre-clinical research work for treating diabetic foot ulcers.
ArthroCare's platform technology is indicated for soft tissue debridement in arthroscopic and orthopedic applications, which includes treating diabetic foot ulcers among other soft tissue conditions.
ArthroCare is evaluating pathways to expand product indications to include diabetic foot ulcers as a specific treatment methodology and will work with FDA for specific product labeling. With hospitalization and amputation often being the only options for patients, ArthroCare's Sports Medicine division is working with surgeons to develop less invasive, more effective alternatives.
Jack Giroux, president of ArthroCare Sports Medicine, said: "We're constantly exploring new applications for our technology that can help surgeons achieve superior outcomes and we think we may have something very special here that could potentially provide a large patient population with relief."
Source: Datamonitor
Related Articles
- MacroChem Announces Presentation By Michael Zasloff, MD, PhD on Topical Therapy for Diabetic Foot Infection
- ArthroCare(R) Sports Medicine to Tackle Diabetic Foot Ulcers
- Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
- IYIA Launches Technology to Reduce Amputations Due to Diabetic Foot Ulcers
- Innocoll Announces Investigational New Drug Application Filing for Its CollaRx GENTAMICIN As a Topical Treatment for Infected Diabetic Foot Ulcers
- IYIA Technologies is Healing Unhealed Diabetic Foot Ulcers
- KeraCure(TM) Initiates Multi-Center Pivotal Study in Diabetic Foot Ulcers
- Cytomedix Announces Preliminary Results of Clinical Trial for Treatment of Diabetic Foot Ulcers
- Cytomedix Completes Treatment Phase of Clinical Trial For Diabetic Foot Ulcers
User Comments (0)
RSS Feeds